Intellectual Property, COVID-19 and the Next Pandemic

This volume critically assesses the role of intellectual property in pandemic times through lessons learned from the COVID-19 pandemic. It broadens our understanding of the implications of intellectual property protection for both the development and distribution of essential technologies such as vaccines.

Introduction: Intellectual property and 'the lost year' of COVID-19 Deaths Madhavi Sunder and Haochen Sun; Part I. Reconsidering Key Theoretical and Policy Issues: 1. New and heightened public-private quid pro quos: leveraging public support to enhance private technical disclosure Peter Lee; 2. Global medical war chest Lawrence O. Gostin; 3. COVID-19 and boundary-crossing collaboration Laura G. Pedraza-Fariña; 4. Legal paradigms and the politics of global COVID-19 vaccine access Matthew M. Kavanagh and Renu Singh; Part II. Boosting Low-Income Countries' Capacities for Protecting Public Health: 5. Fostering production of pharmaceutical products in developing countries William Fisher, Ruth Okediji and Padmashree Gehl Sampath; 6. Patent philanthropy Haochen Sun; 7. Beyond traditional IP: addressing regulatory barriers Cynthia M. Ho; 8. Capability approach to developing global health initiatives for equitable access to vaccines Calvin WL Ho; Part III. Alternative Means of Fighting Pandemics: 9. Planning for pandemic and epidemic-related scarcity of medicines Sapna Kumar & Ana Santos Rutschman; 10. Improving global governance of pandemic response: lessons from COVID-19 Jayashree Watal; 11. Compelling trade secret sharing David S. Levine & Joshua D. Sarnoff; 12. Voluntary intellectual property pledges and COVID-19 Jorge L. Contreras; Part IV. Toward Dynamic Protection of Public Health in China, Africa and Latin America: 13. The TRIPS waiver and the global pandemic response Peter K. Yu, China; 14. COVID-19 exclusion, policy contagion, and colonial hangover in Africa Olufunmilayo Arewa; 15. Technology transfer for production of COVID-19 vaccines in Latin America Kenneth C. Shadlen.